Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Human Molecular Genetics

Volumn 23, Issue 24, 2014, Pages 6616-6633

  Wang, Zhaoming ^a,b   Zhu, Bin ^a   Zhang, Mingfeng ^a   Parikh, Hemang ^a   Jia, Jinping ^a   Chung, Charles C ^a,b   Sampson, Joshua N ^a   Hoskins, Jason W ^a   Hutchinson, Amy ^a,b   Burdette, Laurie ^a,b   Ibrahim, Abdisamad ^a   Hautman, Christopher ^a,b   Raj, Preethi S ^a   Abnet, Christian C ^a   Adjei, Andrew A ^c,d   Ahlbom, Anders ^e   Albanes, Demetrius ^a   Allen, Naomi E ^f   Ambrosone, Christine B ^g   Aldrich, Melinda ^h,i   Amiano, Pilar ^j,k   Amos, Christopher ^l   Andersson, Ulrika ^m   Gerald Andriole, G A ⁿ   Andrulis, Irene L ^o   Arici, Cecilia ^p   Arslan, Alan A ^q,r   Austin, Melissa A ^s   Baris, Dalsu ^a   Barkauskas, Donald A ^t   Bassig, Bryan A ^a,u   Freeman, Laura E Beane ^a   Berg, Christine D ^a   Berndt, Sonja I ^a   Bertazzi, Pier Alberto ^v,w   Biritwum, Richard B ^c,d   Black, Amanda ^a   Blot, William ^h,i,x   Boeing, Heiner ^y   Boffetta, Paolo ^z   Bolton, Kelly ^a,aa   Boutron Ruault, Marie Christine ^ab   Bracci, Paige M ^ac   Brennan, Paul ^ad   Brinton, Louise A ^a   Brotzman, Michelle ^ae   Bueno de Mesquita, H Bas ^af,ag   Buring, Julie E ^ah   Butler, Mary Ann ^ai   Cai, Qiuyin ^h,i   Cancel Tassin, Geraldine ^aj,al   Canzian, Federico ^am   Cao, Guangwen ^an   Caporaso, Neil E ^a   Carrato, Alfredo ^ao   Carreon, Tania ^ai   Carta, Angela ^o   Chang, Gee Chen ^ap,aq   Chang, I Shou ^ar   Chang Claude, Jenny ^am   Che, Xu ^au   Chen, Chien Jen ^aw,ax   Chen, Chih Yi ^ay   Chen, Chung Hsing ^ar   Chen, Constance ^az   Chen, Kuan Yu ^ba   Chen, Yuh Min ^bb,bd,be   Chokkalingam, Anand P ^bf   Chu, Lisa W ^bg   Clavel Chapelon, Francoise ^bh   Colditz, Graham A ⁿ   Colt, Joanne S ^a   Conti, David ^t   Cook, Michael B ^a   Cortessis, Victoria K ^t   Crawford, E David ^bi   Cussenot, Olivier ^aj,ak,al   Davis, Faith G ^bj   De Vivo, Immaculata ^ah,az,bk   Deng, Xiang ^a,b   Ding, Ti ^bl   Dinney, Colin P ^bm   Di Stefano, Anna Luisa ^bp   Diver, W Ryan ^bq   Duell, Eric J ^br   Elena, Joanne W ^bs   Fan, Jin Hu ^bt   Feigelson, Heather Spencer ^bu   Feychting, Maria ^e   Figueroa, Jonine D ^a   Flanagan, Adrienne M ^bv,bw   Fraumeni, Joseph F ^a   Freedman, Neal D ^a   Fridley, Brooke L ^bx   Fuchs, Charles S ^bk,by   Gago Dominguez, Manuela ^ca   Gallinger, Steven ^o   Gao, Yu Tang ^cc   Gapstur, Susan M ^bq   Garcia Closas, Montserrat ^a,cd   Garcia Closas, Reina ^ce   Gastier Foster, Julie M ^cf   Gaziano, J Michael ^ah,bz,cg   Gerhard, Daniela S ^a   Giffen, Carol A ^ch   Giles, Graham G ^ci   Gillanders, Elizabeth M ^a   Giovannucci, Edward L ^az   Goggins, Michael ^cj   Gokgoz, Nalan ^cb   Goldstein, Alisa M ^a   Gonzalez, Carlos ^ck   Gorlick, Richard ^cl   Greene, Mark H ^a   Gross, Myron ^cm   Grossman, H Barton ^bm   Grubb, Robert ⁿ   Gu, Jian ^bm   Guan, Peng ^cn   Haiman, Christopher A ^t   Hallmans, Goran ^m   Hankinson, Susan E ^bk   Harris, Curtis C ^a   Hartge, Patricia ^a   Hattinger, Claudia ^co   Hayes, Richard B ^a,cp   He, Qincheng ^cn   Helman, Lee ^a   Henderson, Brian E ^t   Henriksson, Roger ^m   Hoffman Bolton, Judith ^cq   Hohensee, Chancellor ^cr   Holly, Elizabeth A ^ac   Hong, Yun Chul ^cs   Hoover, Robert N ^a   Dean Hosgood, H ^cl   Hsiao, Chin Fu ^as,at   Hsing, Ann W ^bg,ct   Hsiung, Chao Agnes ^as   Hu, Nan ^a   Hu, Wei ^a   Hu, Zhibin ^cu   Huang, Ming Shyan ^ba   Hunter, David J ^ah,az,bk,cv   Inskip, Peter D ^a   Ito, Hidemi ^cw   Jacobs, Eric J ^bq   Jacobs, Kevin B ^a,b,cx   Jenab, Mazda ^ad   Ji, Bu Tian ^a   Johansen, Christoffer ^cy,cz   Johansson, Mattias ^m,ad   Johnson, Alison ^da   Kaaks, Rudolf ^am   Kamat, Ashish M ^bm   Kamineni, Aruna ^db   Karagas, Margaret ^l   Khanna, Chand ^a   Khaw, Kay Tee ^dd   Kim, Christopher ^a   Kim, In Sam ^de,df   Kim, Jin Hee ^cs   Kim, Yeul Hong ^dg,dh   Kim, Young Chul ^di   Kim, Young Tae ^cs   Kang, Chang Hyun ^cs   Jung, Yoo Jin ^cs   Kitahara, Cari M ^a   Klein, Alison P ^cj,cq   Klein, Robert ^dj   Kogevinas, Manolis ^k,dk,dl,dm   Koh, Woon Puay ^bc,dn   Kohno, Takashi ^do   Kolonel, Laurence N ^dp   Kooperberg, Charles ^cr   Kratz, Christian P ^a,fq   Krogh, Vittorio ^dq   Kunitoh, Hideo ^do,dr   Kurtz, Robert C ^dj   Kurucu, Nilgun ^ds   Lan, Qing ^a   Lathrop, Mark ^dt,du   Lau, Ching C ^dv   Lecanda, Fernando ^dx   Lee, Kyoung Mu ^cs,fp   Lee, Maxwell P ^a   Marchand, Loic Le ^dp   Lerner, Seth P ^dw   Li, Donghui ^bm   Liao, Linda M ^a   Lim, Wei Yen ^bc   Lin, Dongxin ^av   Lin, Jie ^bm   Lindstrom, Sara ^az   Linet, Martha S ^a   Lissowska, Jolanta ^dy   Liu, Jianjun ^dz,ea   Ljungberg, Börje ^m   Lloreta, Josep ^k   Lu, Daru ^eb   Ma, Jing ^ah,bk   Malats, Nuria ^ec   Mannisto, Satu ^ed   Marina, Neyssa ^ee   Mastrangelo, Giuseppe ^ef   Matsuo, Keitaro ^cw,eg   McGlynn, Katherine A ^a   McKean Cowdin, Roberta ^bm   McNeil, Lorna H ^bn   McWilliams, Robert R ^eh   Melin, Beatrice S ^m   Meltzer, Paul S ^a   Mensah, James E ^c,d   Miao, Xiaoping ^ei   Michaud, Dominique S ^ej   Mondul, Alison M ^a   Moore, Lee E ^a   Muir, Kenneth ^ek   Niwa, Shelley ^ae   Olson, Sara H ^dj   Orr, Nick ^cd   Panico, Salvatore ^el   Park, Jae Yong ^de,df,em   Patel, Alpa V ^bq   Patino Garcia, Ana ^dx   Pavanello, Sofia ^ef   Peeters, Petra H M ^ag,en   Peplonska, Beata ^eo   Peters, Ulrike ^cr   Petersen, Gloria M ^eh   Picci, Piero ^co   Pike, Malcolm C ^t,dj   Porru, Stefano ^p   Prescott, Jennifer ^ah,az,bk   Pu, Xia ^bm   Purdue, Mark P ^a   Qiao, You Lin ^au   Rajaraman, Preetha ^a   Riboli, Elio ^en   Risch, Harvey A ^u   Rodabough, Rebecca J ^cr   Rothman, Nathaniel ^a   Ruder, Avima M ^ai   Ryu, Jeong Seon ^ep   Sanson, Marc ^bp   Schned, Alan ^l   Schumacher, Fredrick R ^t   Schwartz, Ann G ^eq   Schwartz, Kendra L ^er   Schwenn, Molly ^es   Scotlandi, Katia ^co   Seow, Adeline ^bc   Serra, Consol ^k,et   Serra, Massimo ^co   Sesso, Howard D ^ah   Severi, Gianluca ^ci   Shen, Hongbing ^cu   Shen, Min ^a   Shete, Sanjay ^bo   Shiraishi, Kouya ^do   Shu, Xiao Ou ^h,i   Siddiq, Afshan ^en   Sierrasesumaga, Luis ^dx   Sierri, Sabina ^dq   Sihoe, Alan Dart Loon ^eu   Silverman, Debra T ^a   Simon, Matthias ^ev   Southey, Melissa C ^ci   Spector, Logan ^ew   Spitz, Margaret ^dw   Stampfer, Meir ^ah,bk   Stattin, Par ^m   Stern, Mariana C ^t   Stevens, Victoria L ^bq   Stolzenberg Solomon, Rachael Z ^a   Stram, Daniel O ^t   Strom, Sara S ^bo   Su, Wu Chou ^ex   Sund, Malin ^m   Sung, Sook Whan ^dc   Swerdlow, Anthony ^cd   Tan, Wen ^av   Tanaka, Hideo ^cw   Tang, Wei ^a   Tang, Ze Zhang ^bl   Tardon, Adonina ^ey   Tay, Evelyn ^c,d   Taylor, Philip R ^a   Tettey, Yao ^c,d   Thomas, David M ^ci   Tirabosco, Roberto ^bw   Tjonneland, Anne ^cz   Tobias, Geoffrey S ^a   Toro, Jorge R ^a   Travis, Ruth C ^f   Trichopoulos, Dimitrios ^az   Troisi, Rebecca ^a   Truelove, Ann ^ae   Tsai, Ying Huang ^ez   Tucker, Margaret A ^a   Tumino, Rosario ^fa   Van Den Berg, David ^t   Van Den Eeden, Stephen K ^bu   Vermeulen, Roel ^fb   Vineis, Paolo ^en,fc   Visvanathan, Kala ^cq   Vogel, Ulla ^fd,fe   Wang, Chaoyu ^a   Wang, Chengfeng ^au   Wang, Junwen ^a,b,ff   Wang, Sophia S ^fh   Weiderpass, Elisabete ^e,fi,fj,fk   Weinstein, Stephanie J ^a   Wentzensen, Nicolas ^a   Wheeler, William ^ch   White, Emily ^cr   Wiencke, John K ^fl   Wolk, Alicja ^e   Wolpin, Brian M ^bk,by   Wong, Maria Pik ^fg   Wrensch, Margaret ^fl   Wu, Chen ^av   Wu, Tangchun ^ef   Wu, Xifeng ^bm   Wu, Yi Long ^fm   Wunder, Jay S ⁿ   Xiang, Yong Bing ^cc   Xu, Jun ^ff   Yang, Hannah P ^a   Yang, Pan Chyr ^ba   Yatabe, Yasushi ^fn   Ye, Yuanqing ^bm   Yeboah, Edward D ^c,d   Yin, Zhihua ^cn   Ying, Chen ^bc   Yu, Chong Jen ^ex   Yu, Kai ^a   Yuan, Jian Min ^fo   Zanetti, Krista A ^bs   Zeleniuch Jacquotte, Anne ^q,r   Zheng, Wei ^h,i   Zhou, Baosen ^cn   Mirabello, Lisa ^a   Savage, Sharon A ^a   Kraft, Peter ^az   Chanock, Stephen J ^a,b   Yeager, Meredith ^a,b   Landi, Maria Terese ^a   Shi, Jianxin ^a   Chatterjee, Nilanjan ^a   Amundadottir, Laufey T ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d UNIVERSITY OF GHANA   (Ghana)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ VANDERBILT INGRAM CANCER CENTER   (United States)

^j Basque Government   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^l DARTMOUTH MEDICAL SCHOOL   (United States)

^m UMEÅ UNIVERSITY   (Sweden)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o MOUNT SINAI HOSPITAL   (Canada)

^p UNIVERSITY OF BRESCIA   (Italy)

^q NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r NEW YORK UNIVERSITY   (United States)

^s UNIVERSITY OF WASHINGTON   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u YALE UNIVERSITY   (United States)

^v UNIVERSITY OF MILAN   (Italy)

^w FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^x INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^y GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^z MOUNT SINAI HOSPITAL   (United States)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab INSERM   (France)

^ac UNIVERSITY OF CALIFORNIA   (United States)

^ad INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ae WESTAT   (United States)

^af NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ag UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ah BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ai NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^aj CeRePP group   (France)

^ak HÔPITAL TENON   (France)

^al SORBONNE UNIVERSITÉ   (France)

^am GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^an SECOND MILITARY MEDICAL UNIVERSITY   (China)

^ao HOSPITAL RAMÓN Y CAJAL   (Spain)

^ap NATIONAL YANG MING UNIVERSITY   (Taiwan)

^aq TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^ar National Institute of Cancer Research   (Taiwan)

^as Institute of Population Health Sciences   (Taiwan)

^at NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^au PEKING UNION MEDICAL COLLEGE   (China)

^av CANCER HOSPITAL   (China)

^aw GENOMICS RESEARCH CENTER   (Taiwan)

^ax NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^ay CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^az HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ba NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^bb NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^bc NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^bd TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^be TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^bf UNIVERSITY OF CALIFORNIA   (United States)

^bg CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^bh CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^bi UNIVERSITY OF COLORADO   (United States)

^bj UNIVERSITY OF ALBERTA   (Canada)

^bk CHANNING LABORATORY   (United States)

^bl SHANXI CANCER HOSPITAL   (China)

^bm Harvard Medical School ^*  (United States)

^bn Duncan Family Institute   (United States)

^bo UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^bp PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^bq AMERICAN CANCER SOCIETY   (United States)

^br BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^bs Cancer Control and Population Sciences   (United States)

^bt SHANGHAI CANCER INSTITUTE   (China)

^bu KAISER PERMANENTE   (United States)

^bv UNIVERSITY COLLEGE LONDON   (United Kingdom)

^bw ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^bx UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^by DANA FARBER CANCER INSTITUTE   (United States)

^bz Division of Preventive Medicine   (United States)

^ca HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^cb MOUNT SINAI HOSPITAL   (Canada)

^cc SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^cd INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ce HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^cf OHIO STATE UNIVERSITY   (United States)

^cg VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ch INFORMATION MANAGEMENT SERVICES INC   (United States)

^ci UNIVERSITY OF MELBOURNE   (Australia)

^cj JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ck CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^cl ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^cm UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^cn CHINA MEDICAL UNIVERSITY   (China)

^co RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^cp NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^cq JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^cr Fred Hutchinson Cancer Research Center   (United States)

^cs Seoul National University College of Medicine   (South Korea)

^ct STANFORD CANCER INSTITUTE   (United States)

^cu NANJING MEDICAL UNIVERSITY   (China)

^cv BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^cw AICHI CANCER CENTER HOSPITAL   (Japan)

^cx BioInformed LLC   (United States)

^cy FINSEN LABORATORY   (Denmark)

^cz DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^da Vermont Cancer Registry   (United States)

^db GROUP HEALTH RESEARCH INSTITUTE   (United States)

^dc The Catholic University of Korea   (South Korea)

^dd UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^de Kyungpook National University   (South Korea)

^df Kyungpook National University School of Medicine   (South Korea)

^dg College of Medicine   (South Korea)

^dh Korea University College of Medicine   (South Korea)

^di Chonnam National University Research Institute of Medical Sciences   (South Korea)

^dj MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^dk CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^dl HOSPITAL DEL MAR   (Spain)

^dm NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^dn DUKE NUS MEDICAL SCHOOL   (Singapore)

^do NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^dp UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^dq NATIONAL CANCER INSTITUTE   (Italy)

^dr MITSUI MEMORIAL HOSPITAL   (Japan)

^ds Ankara Oncol Training/Res Hospital   (Turkey)

^dt DIF   (France)

^du FONDATION JEAN DAUSSET CEPH   (France)

^dv Texas Children's Cancer and Hematology Centers   (United States)

^dw BAYLOR COLLEGE OF MEDICINE   (United States)

^dx UNIVERSITY CLINIC OF NAVARRA   (Spain)

^dy INSTITUTE OF ONCOLOGY   (Poland)

^dz GENOME INSTITUTE OF SINGAPORE   (Singapore)

^ea ANHUI MEDICAL UNIVERSITY   (China)

^eb FUDAN UNIVERSITY   (China)

^ec Structural Biology and Biocomputing Programme   (Spain)

^ed NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ee STANFORD UNIVERSITY   (United States)

^ef UNIVERSITY OF PADOVA   (Italy)

^eg KYUSHU UNIVERSITY   (Japan)

^eh MAYO CLINIC   (United States)

^ei HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^ej BROWN UNIVERSITY   (United States)

^ek UNIVERSITY OF WARWICK   (United Kingdom)

^el UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^em Kyungpook National University School of Medicine   (South Korea)

^en IMPERIAL COLLEGE LONDON   (United Kingdom)

^eo NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^ep Inha University School of Medicine   (South Korea)

^eq KARMANOS CANCER INSTITUTE   (United States)

^er WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^es Maine Cancer Registry   (United States)

^et UNIVERSITAT POMPEU FABRA   (Spain)

^eu QUEEN MARY HOSPITAL   (Hong Kong)

^ev UNIVERSITY HOSPITAL BONN   (Germany)

^ew UNIVERSITY OF MINNESOTA   (United States)

^ex NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^ey UNIVERSITY OF OVIEDO   (Spain)

^ez CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^fa Cancer Registry Associazione Iblea Ricerca Epidemiologica   (Italy)

^fb UTRECHT UNIVERSITY   (Netherlands)

^fc Human Genetics Foundation   (Italy)

^fd NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^fe TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^ff UNIVERSITY OF HONG KONG   (Hong Kong)

^fg UNIVERSITY OF HONG KONG   (Hong Kong)

^fh CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^fi UNIVERSITY OF TROMSØ   (Norway)

^fj CANCER REGISTRY OF NORWAY   (Norway)

^fk FOLKHÄLSAN RESEARCH CENTER   (Finland)

^fl UNIVERSITY OF CALIFORNIA   (United States)

^fm GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^fn Department of Pathology and Molecular Diagnostics   (United States)

^fo UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^fp Korea National Open University   (South Korea)

^fq HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; CLPTM1L PROTEIN, HUMAN; MEMBRANE PROTEIN; TELOMERASE; TERT PROTEIN, HUMAN; TUMOR PROTEIN;

ALLELE; APOPTOSIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 5P; CLPTM1L GENE; DNA METHYLATION; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; ONCOGENE; PLEIOTROPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; BIOLOGY; CHEMISTRY; CHROMOSOME 5; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; MULTICENTER STUDY; NEOPLASM; ODDS RATIO; PATHOLOGY; RISK;

ALLELES; CHROMOSOMES, HUMAN, PAIR 5; COMPUTATIONAL BIOLOGY; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TELOMERASE;

EID: 84938138638     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu363     Document Type: Article

References (89)

1. Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J.D., Real, F.X., Van Den Berg, D., Matullo, G., Baris, D. et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet., 42, 978-984.
2. Haiman, C.A., Chen, G.K., Vachon, C.M., Canzian, F., Dunning, A., Millikan, R.C., Wang, X., Ademuyiwa, F., Ahmed, S., Ambrosone, C.B. et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet., 43, 1210-1214.
3. Shete, S., Hosking, F.J., Robertson, L.B., Dobbins, S.E., Sanson, M., Malmer, B., Simon, M., Marie, Y., Boisselier, B., Delattre, J.Y. et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet., 41, 899-904.
4. Wang, Y., Broderick, P., Webb, E., Wu, X., Vijayakrishnan, J., Matakidou, A., Qureshi, M., Dong, Q., Gu, X., Chen, W.V. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
5. McKay, J.D., Hung, R.J., Gaborieau, V., Boffetta, P., Chabrier, A., Byrnes, G., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J. et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
6. Broderick, P., Wang, Y., Vijayakrishnan, J., Matakidou, A., Spitz, M.R., Eisen, T., Amos, C.I. and Houlston, R.S. (2009) Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res., 69, 6633-6641.
7. Landi, M.T., Chatterjee, N., Yu, K., Goldin, L.R., Goldstein, A.M., Rotunno, M., Mirabello, L., Jacobs, K., Wheeler, W., Yeager, M. et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet., 85, 679-691.
8. Beesley, J., Pickett, H.A., Johnatty, S.E., Dunning, A.M., Chen, X., Li, J., Michailidou, K., Lu, Y., Rider, D.N., Palmieri, R.T. et al. (2011) Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS ONE, 6, e24987.
9. Rafnar, T., Sulem, P., Stacey, S.N., Geller, F., Gudmundsson, J., Sigurdsson, A., Jakobsdottir, M., Helgadottir, H., Thorlacius, S., Aben, K.K. et al. (2009) Sequence variants at theTERT-CLPTM1Llocus associate withmanycancer types. Nat. Genet., 41, 221-227.
10. Stacey, S.N., Sulem, P., Masson, G., Gudjonsson, S.A., Thorleifsson, G., Jakobsdottir, M., Sigurdsson, A., Gudbjartsson, D.F., Sigurgeirsson, B., Benediktsdottir, K.R. et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet., 41, 909-914.
11. Yang, X., Yang, B., Li, B. and Liu, Y. (2013) Association between TERT-CLPTM1L rs401681[C] allele and NMSC cancer risk: a meta-analysis including 45,184 subjects. Arch. Dermatol. Res., 1, 49-52.
12. Petersen, G.M., Amundadottir, L., Fuchs, C.S., Kraft, P., Stolzenberg-Solomon, R.Z., Jacobs, K.B., Arslan, A.A., Bueno-de-Mesquita, H.B., Gallinger, S., Gross, M. et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet., 42, 224-228.
13. Kote-Jarai, Z., Olama, A.A., Giles, G.G., Severi, G., Schleutker, J., Weischer, M., Campa, D., Riboli, E., Key, T., Gronberg, H. et al. (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat. Genet., 43, 785-791.
14. Turnbull, C., Rapley, E.A., Seal, S., Pernet, D., Renwick, A., Hughes, D., Ricketts, M., Linger, R., Nsengimana, J., Deloukas, P. et al. (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat. Genet., 42, 604-607.
15. Mocellin, S., Verdi, D., Pooley, K.A., Landi, M.T., Egan, K.M., Baird, D.M., Prescott, J., De Vivo, I. and Nitti, D. (2012) Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J. Natl. Cancer Inst., 104, 840-854.
16. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science, 266, 2011-2015.
17. Yamamoto, K., Okamoto, A., Isonishi, S., Ochiai, K. and Ohtake, Y. (2001) A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem. Biophys. Res. Commun., 280, 1148-1154.
18. James, M.A., Wen, W., Wang, Y., Byers, L.A., Heymach, J.V., Coombes, K.R., Girard, L., Minna, J. and You, M.(2012) Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS ONE, 7, e36116.
19. Ni, Z., Tao, K., Chen, G., Chen, Q., Tang, J., Luo, X., Yin, P. and Wang, X. (2012) CLPTM1L is overexpressed in lung cancer and associated with apoptosis. PLoS ONE, 7, e52598.
20. Jia, J., Bosley, A.D., Thompson, A., Hoskins, J.W., Cheuk, A., Collins, I., Parikh, H., Xiao, Z., Ylaya, K., Dzyadyk, M. et al. (2014) CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Cancer Res., 74, 2785-2795.
21. James, M.A., Vikis, H.G., Tate, E., Rymaszewski, A.L. and You, M. (2014) CRR9/CLPTM1LRegulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis. Cancer Res., 74, 1116-1127.
22. Ballew, B.J. and Savage, S.A. (2013) Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev. Hematol., 6, 327-337.
23. Armanios, M. and Blackburn, E.H. (2012) The telomere syndromes. Nat. Rev. Genet., 13, 693-704.
24. Bhattacharjee, S., Rajaraman, P., Jacobs, K.B., Wheeler, W.A., Melin, B.S., Hartge, P., Yeager, M., Chung, C.C., Chanock, S.J. and Chatterjee, N. (2012) A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. Am. J. Hum. Genet., 90, 821-835.
25. Genomes. (2010) A map of human genome variation from population-scale sequencing. Nature, 467, 1061-1073.
26. Wang, Z., Jacobs, K.B., Yeager, M., Hutchinson, A., Sampson, J., Chatterjee, N., Albanes, D., Berndt, S.I., Chung, C.C., Diver, W.R. et al. (2012) Improved imputation of common and uncommon SNPs with a new reference set. Nat. Genet., 44, 6-7.
27. Rajaraman, P., Melin, B.S., Wang, Z., McKean-Cowdin, R., Michaud, D.S., Wang, S.S., Bondy, M., Houlston, R., Jenkins, R.B., Wrensch, M. et al. (2012) Genome-wide association study of glioma and meta-analysis. Hum. Genet., 131, 1877-1888.
28. Shi, J., Marconett, C.N., Duan, J., Hyland, P.L., Li, P., Wang, Z., Wheeler, W., Zhou, B., Campan, M., Lee, D.S. et al. (2014) Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nat. Commun., 5, 3365.
29. Cheung, A.L. and Deng, W. (2008) Telomere dysfunction, genome instability and cancer. Front. Biosci., 13, 2075-2090.
30. Cesare, A.J. and Reddel, R.R. (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat. Rev. Genet., 11, 319-330.
31. Shay, J.W. and Bacchetti, S. (1997)Asurvey of telomerase activity in human cancer. Eur. J. Cancer, 33, 787-791.
32. Hou, L., Zhang, X., Gawron, A.J. and Liu, J. (2012) Surrogate tissue telomere length and cancer risk: shorter or longer? Cancer Lett., 319, 130-135.
33. Pooley, K.A., Sandhu, M.S., Tyrer, J., Shah, M., Driver, K.E., Luben, R.N., Bingham, S.A., Ponder, B.A., Pharoah, P.D., Khaw, K.T. et al. (2010) Telomere length in prospective and retrospective cancer case-control studies. Cancer Res., 70, 3170-3176.
34. De Vivo, I., Prescott, J., Wong, J.Y., Kraft, P., Hankinson, S.E. and Hunter, D.J. (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 18, 1152-1156.
35. Weischer, M., Nordestgaard, B.G., Cawthon, R.M., Freiberg, J.J., Tybjaerg-Hansen, A. and Bojesen, S.E. (2013) Short telomere length, cancer survival, and cancer risk in 47102 individuals. J. Natl. Cancer Inst., 105, 459-468.
36. Slagboom, P.E., Droog, S. andBoomsma, D.I. (1994) Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet., 55, 876-882.
37. Andrew, T., Aviv, A., Falchi, M., Surdulescu, G.L., Gardner, J.P., Lu, X., Kimura, M., Kato, B.S., Valdes, A.M. and Spector, T.D. (2006) Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am. J. Hum. Genet., 78, 480-486.
38. Nan, H., Qureshi, A.A., Prescott, J., De Vivo, I. and Han, J. (2011) Genetic variants in telomere-maintaining genes and skin cancer risk. Hum. Genet., 129, 247-253.
39. Melin, B.S., Nordfjall, K., Andersson, U. and Roos, G. (2012)hTERTcancer risk genotypes are associated with telomere length. Genet. Epidemiol., 36, 368-372.
40. Hsu, C.P., Hsu, N.Y., Lee, L.W. and Ko, J.L. (2006) Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter-effect on telomerase expression and telomere length maintenance in non-small cell lung cancer. Eur. J. Cancer, 42, 1466-1474.
41. Horn, S., Figl, A., Rachakonda, P.S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K. et al. (2013) TERT promoter mutations in familial and sporadic melanoma. Science, 339, 959-961.
42. Killela, P.J., Reitman, Z.J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L.A. Jr, Friedman, A.H., Friedman, H., Gallia, G.L., Giovanella, B.C. et al. (2013)TERTpromoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl. Acad. Sci. USA, 110, 6021-6026.
43. Simon, M., Hosking, F.J., Marie, Y., Gousias, K., Boisselier, B., Carpentier, C., Schramm, J., Mokhtari, K., Hoang-Xuan, K., Idbaih, A. et al. (2010) Genetic risk profiles identify different molecular etiologies for glioma. Clin. Cancer Res., 16, 5252-5259.
44. Yang, P., Li, Y., Jiang, R., Cunningham, J.M., Zhang, F. and de Andrade, M. (2010) A rigorous and comprehensive validation: common genetic variations and lung cancer. Cancer Epidemiol. Biomarkers Prev., 19, 240-244.
45. Hu, Z., Wu, C., Shi, Y., Guo, H., Zhao, X., Yin, Z., Yang, L., Dai, J., Hu, L., Tan, W. et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet., 43, 792-796.
46. Miki, D., Kubo, M., Takahashi, A., Yoon, K.A., Kim, J., Lee, G.K., Zo, J.I., Lee, J.S., Hosono, N., Morizono, T. et al. (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat. Genet., 42, 893-896.
47. Pande, M., Spitz, M.R., Wu, X., Gorlov, I.P., Chen, W.V. and Amos, C.I. (2011) Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis, 32, 1493-1499.
48. Johnatty, S.E., Beesley, J., Chen, X., Macgregor, S., Duffy, D.L., Spurdle, A.B., deFazio, A., Gava, N., Webb, P.M., Rossing, M.A. et al. (2010) Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility 'hot-spot'. PLoS Genet., 6, e1001016.
49. Zhao, Y., Chen, G., Song, X., Chen, H., Mao, Y. and Lu, D. (2012) Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population. Int. J. Cancer, 131, 1569-1576.
50. Shiraishi, K., Kunitoh, H., Daigo, Y., Takahashi, A., Goto, K., Sakamoto, H., Ohnami, S., Shimada, Y., Ashikawa, K., Saito, A. et al. (2012) A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat. Genet., 44, 900-903.
51. Palmer, J.R., Ruiz-Narvaez, E.A., Rotimi, C.N., Cupples, L.A., Cozier, Y.C., Adams-Campbell, L.L. and Rosenberg, L. (2012) Genetic susceptibility loci for subtypes of breast cancer in an African American population. Cancer Epidemiol. Biomarkers Prev., 22, 127-34.
52. Barrett, J.H., Iles, M.M., Harland, M., Taylor, J.C., Aitken, J.F., Andresen, P.A., Akslen, L.A., Armstrong, B.K., Avril, M.F., Azizi, E. et al. (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat. Genet., 43, 1108-1113.
53. Bojesen, S.E., Pooley, K.A., Johnatty, S.E., Beesley, J., Michailidou, K., Tyrer, J.P., Edwards, S.L., Pickett, H.A., Shen, H.C., Smart, C.E. et al. (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet., 45, 371-384.
54. Kote-Jarai, Z., Saunders, E.J., Leongamornlert, D.A., Tymrakiewicz, M., Dadaev, T., Jugurnauth-Little, S., Ross-Adams, H., Al Olama, A.A., Benlloch, S., Halim, S. et al. (2013) Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum. Mol. Genet., 22, 2520-2528.
55. Grundberg, E., Meduri, E., Sandling, J.K., Hedman, A.K., Keildson, S., Buil, A., Busche, S., Yuan, W., Nisbet, J., Sekowska, M. et al. (2013) Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am. J. Hum. Genet., 93, 876-890.
56. Irizarry, R.A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M. et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet., 41, 178-186.
57. Jjingo, D., Conley, A.B., Yi, S.V., Lunyak, V.V. and Jordan, I.K. (2012) On the presence and role of human gene-bodyDNAmethylation. Oncotarget, 3, 462-474.
58. Rideout, W.M. III, Coetzee, G.A., Olumi, A.F. and Jones, P.A. (1990) 5-Methylcytosine as an endogenousmutagen in thehumanLDLreceptor and p53 genes. Science, 249, 1288-1290.
59. Maunakea, A.K., Nagarajan, R.P., Bilenky, M., Ballinger, T.J., D'Souza, C., Fouse, S.D., Johnson, B.E., Hong, C., Nielsen, C., Zhao, Y. et al. (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature, 466, 253-257.
60. Shen, H. and Laird, P.W. (2013) Interplay between the cancer genome and epigenome. Cell, 153, 38-55.
61. Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M. and Smoller, J.W. (2013) Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet., 14, 483-495.
62. Figueroa JD, Y.Y., Siddiq, A., Garcia-Closas, M., Chatterjee, N. et al. (2014) Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum. Mol. Genet., 23, 1387-1398.
63. Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
64. Siddiq, A., Couch, F.J., Chen, G.K., Lindstrom, S., Eccles, D., Millikan, R.C., Michailidou, K., Stram, D.O., Beckmann, L., Rhie, S.K. et al. (2012)A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum. Mol. Genet., 21, 5373-5384.
65. De Vivo, I., Prescott, J., Setiawan, V.W., Olson, S.H. and Wentzensen, N., Australian National Endometrial Cancer Study Group, Attia, J., Black, A., Brinton, L., Chen, C. et al. (2014) Genome-wide association study of endometrial cancer in E2C2. Hum. Genet. 133, 211-24.
66. Abnet, C.C., Freedman, N.D., Hu, N., Wang, Z., Yu, K., Shu, X.O., Yuan, J.M., Zheng, W., Dawsey, S.M., Dong, L.M. et al. (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet., 42, 764-767.
67. Hinch, A.G., Tandon, A., Patterson, N., Song, Y., Rohland, N., Palmer, C.D., Chen, G.K., Wang, K., Buxbaum, S.G., Akylbekova, E.L. et al. (2011) The landscape of recombination in African Americans. Nature, 476, 170-175.
68. Hsiung, C.A., Lan, Q., Hong, Y.C., Chen, C.J., Hosgood, H.D., Chang, I.S., Chatterjee, N., Brennan, P., Wu, C., Zheng, W. et al. (2010) The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet., 6.
69. Lan, Q., Hsiung, C.A., Matsuo, K., Hong, Y.C., Seow, A., Wang, Z., Hosgood, H.D. 3rd, Chen, K., Wang, J.C., Chatterjee, N. et al. (2012) Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat. Genet., 44, 1330-1335.
70. Savage, S.A., Mirabello, L., Wang, Z., Gastier-Foster, J.M., Gorlick, R., Khanna, C., Flanagan, A.M., Tirabosco, R., Andrulis, I.L., Wunder, J.S. et al. (2013) Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat. Genet., 45, 799-803.
71. Bolton, K.L., Tyrer, J., Song, H., Ramus, S.J., Notaridou, M., Jones, C., Sher, T., Gentry-Maharaj, A., Wozniak, E., Tsai, Y.Y. et al. (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat. Genet., 42, 880-884.
72. Amundadottir, L., Kraft, P., Stolzenberg-Solomon, R.Z., Fuchs, C.S., Petersen, G.M., Arslan, A.A., Bueno-de-Mesquita, H.B., Gross, M., Helzlsouer, K., Jacobs, E.J. et al. (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet., 41, 986-990.
73. Wu, C., Miao, X., Huang, L., Che, X., Jiang, G., Yu, D., Yang, X., Cao, G., Hu, Z., Zhou, Y. et al. (2012) Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat. Genet., 44, 62-66.
74. Thomas, G., Jacobs, K.B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
75. Schumacher, F.R., Berndt, S.I., Siddiq, A., Jacobs, K.B., Wang, Z., Lindstrom, S., Stevens, V.L., Chen, C., Mondul, A.M., Travis, R.C. et al. (2011) Genome-wide association study identifies new prostate cancer susceptibility loci. Hum. Mol. Genet., 20, 3867-3875.
76. Purdue, M.P., Johansson, M., Zelenika, D., Toro, J.R., Scelo, G., Moore, L.E., Prokhortchouk, E., Wu, X., Kiemeney, L.A., Gaborieau, V. et al. (2011)Genome-wideassociation study of renal cell carcinoma identifiestwo susceptibility loci on 2p21 and 11q13.3. Nat. Genet., 43, 60-65.
77. Schumacher, F.R., Wang, Z., Skotheim, R.I., Koster, R., Chung, C.C., Hildebrandt, M.A., Kratz, C.P., Bakken, A.C., Timothy Bishop, D., Cook, M.B. et al. (2013) Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum. Mol. Genet., 22, 48-53.
78. Marchini, J. and Howie, B. (2010) Genotype imputation for genome-wide association studies. Nat. Rev. Genet., 11, 499-511.
79. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
80. Fearnhead, P. (2006) SequenceLDhot: detecting recombination hotspots. Bioinformatics, 22, 3061-3066.
81. Fearnhead, P. and Donnelly, P. (2002) Approximate likelihood methods for estimating local recombination rates. J. R. Stat. Soc., 64, 657-680.
82. Li, N. and Stephens, M. (2003) Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. Genetics, 165, 2213-2233.
83. Crawford, D.C., Bhangale, T., Li, N., Hellenthal, G., Rieder, M.J., Nickerson, D.A. and Stephens, M. (2004) Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat. Genet., 36, 700-706.
84. Browning, B.L. and Browning, S.R. (2009) A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet., 84, 210-223.
85. Ward, L.D. and Kellis, M. (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res., 40, D930-934.
86. Boyle, A.P., Hong, E.L., Hariharan, M., Cheng, Y., Schaub, M.A., Kasowski, M., Karczewski, K.J., Park, J., Hitz, B.C., Weng, S. et al. (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res., 22, 1790-1797.
87. Grundberg, E., Small, K.S., Hedman, A.K., Nica, A.C., Buil, A., Keildson, S., Bell, J.T., Yang, T.P., Meduri, E., Barrett, A. et al. (2012) Mapping cisand trans-regulatory effects across multiple tissues in twins. Nat. Genet., 44, 1084-1089.
88. Hebsgaard, S.M., Korning, P.G., Tolstrup, N., Engelbrecht, J., Rouze, P. and Brunak, S. (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res., 24, 3439-3452.
89. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. B, 57, 289-300.